Dr. Lilly Yue is Deputy Director, Division of Biostatistics (DBS), CDRH/FDA, and oversees statistical reviews of therapeutic and diagnostic devices. She also leads DBS’s efforts on advancing regulatory science by developing, implementing, and promoting innovative statistical methodology in the design, analysis, and evaluation of clinical evidence. She serves as an Editor-in-Chief of Pharmaceutical Statistics and is a Fellow of the American Statistical Association.